|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
InVivo Therapeutics Corporation to Present on "Neurodegenerative Disease and Spinal Cord Injury Panel" at Clinical Outlooks for Regenerative Medicine Conference
6/14/2012 11:05:51 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that Ed Wirth, MD, PhD, InVivo’s Chief Science Officer, is scheduled to present at the Clinical Outlooks for Regenerative Medicine Conference on Tuesday, June 19, 2012. Dr. Wirth will speak on the "Neurodegenerative Disease and Spinal Cord Injury Panel" at 1:30 pm. The conference, organized jointly by the Alliance for Regenerative Medicine and the Harvard Stem Cell Institute, will be held at the Starr Center in the Schepens Eye Research Institute in Boston, MA.
|
|
|
|
|
|
|
|
|
|
|